Dr. Ranjita Shegokar

Free University of Berlin, Germany

Email: [email protected]

Qualifications

2010 Ph.D., SNDT University, India

2003 M.Sc., SNDT University, India

2001 B.Sc., BAMU University, India

Publications (selected)

1. Keck, H. S., Weinreich, F.-J., Shegokar, R., et al. (2021). Experimental evaluation of icodextrin delivery as pressurized aerosol (PIPAC): Antiadhesive and cytotoxic effects. EJSO, 47(6), 1434–1440.
2. Castagna, A., Zander, A. J., Sautkin, I., et al. (2020). Enhanced intraperitoneal delivery of charged, aerosolized curcumin nanoparticles by electrostatic precipitation. Nanomedicine, 16(2), 109–120.
3. D'Souza, A., & Shegokar, R. (2021). Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil). Current Drug Delivery, 18(3), 249–270.
4. Hebbink, G., Shegokar, R., & van Gessel, S. (2018). Synergistic effects of three functional excipients in a tablet. Drug Development and Industrial Pharmacy, 44(5), 870.
5. Odei-Addo, F., Shegokar, R., Müller, R. H., et al. (2017). Nanoformulation of Leonotis leonurus to improve its bioavailability as a potential antidiabetic drug. 3 Biotech, 7, Article 344.
6. D'souza, A. A., & Shegokar, R. (2016). Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications. Expert Opinion on Drug Delivery, 13(9), 1257–1275.
7. Doktorovova, S., Shegokar, R., Fernandes, L., et al. (2014). Trehalose is not a universal solution for solid lipid nanoparticles freeze-drying. Pharmaceutical Development and Technology, 19(8), 922–929.
8. Shukla, P., Rao, G. M., Pandey, G., et al. (2014). Therapeutic interventions in sepsis: current and anticipated pharmacological agents. British Journal of Pharmacology, 171(22), 5011–5031.
9. Martena, V., Shegokar, R., Di Martino, P., & Müller, R. H. (2014). Effect of four different size reduction methods on the particle size, solubility enhancement and physical stability of nicergoline nanocrystals. Drug Development and Industrial Pharmacy, 40(9), 1199–1205.
10. Kakran, M., Shegokar, R., Sahoo, N. G., et al. (2012). Long-term stability of quercetin nanocrystals prepared by different methods. Journal of Pharmacy and Pharmacology, 64(10), 1394–1402.
11. Doktorovova, S., Shegokar, R., Martins-Lopes, P., et al. (2012). Modified Rose Bengal assay for surface hydrophobicity evaluation of cationic solid lipid nanoparticles (cSLN). European Journal of Pharmaceutical Sciences, 45(5), 606–612.
12. Kakran, M., Shegokar, R., Sahoo, N. G., et al. (2012). Fabrication of quercetin nanocrystals: Comparison of different methods. European Journal of Pharmaceutics and Biopharmaceutics, 80(1), 113–121.
13. Shegokar, R., & Singh, K. K. (2011). Surface modified nevirapine nanosuspensions for viral reservoir targeting: In vitro and in vivo evaluation. International Journal of Pharmaceutics, 421(2), 341–352.
14. Doktorovova, S., Shegokar, R., Rakovsky, E., et al. (2011). Cationic solid lipid nanoparticles (cSLN): Structure, stability and DNA binding capacity correlation studies. International Journal of Pharmaceutics, 420(2), 341–349.
15. Al Shaal, L., Shegokar, R., & Müller, R. H. (2011). Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulation. International Journal of Pharmaceutics, 420(1), 133–140.
16. Mitri, K., Shegokar, R., Gohla, S., et al. (2011). Lutein nanocrystals as antioxidant formulation for oral and dermal delivery. International Journal of Pharmaceutics, 420(1), 141–146.
17. Shegokar, R., Singh, K. K., & Müller, R. H. (2011). Production & stability of stavudine solid lipid nanoparticles-From lab to industrial scale. International Journal of Pharmaceutics, 416(2), 461–470.
18. Mitri, K., Shegokar, R., Gohla, S., et al. (2011). Lipid nanocarriers for dermal delivery of lutein: Preparation, characterization, stability and performance. International Journal of Pharmaceutics, 414(1-2), 267–275.
19. Shegokar, R., & Singh, K. K. (2011). Nevirapine nanosuspensions for HIV reservoir targeting. Pharmazie, 66(6), 408–415.
20. Shegokar, R., Jansch, M., Singh, K. K., & Müller, R. H. (2011). In vitro protein adsorption studies on nevirapine nanosuspensions for HIV/AIDS chemotherapy. Nanomedicine-Nanotechnology Biology and Medicine, 7(3), 333–340.

Profile Details
https://ranjitas.com/
https://www.researchgate.net/profile/Ranjita-Shegokar
https://scholar.google.com/citations?user=61IKOw8AAAAJ&hl=en

WOS ResearcherID: DQX-0786-2022